Desmeninol

DB15832InvestigationalSmall molecule

Desmeninol is an amino acid derivative indicated in the management of balanced protein metabolism in patients with renal dysfunction. A medication used to prevent a side effect in patients with kidney disorders on a low protein diet.

Chemical structure of Desmeninol
Mechanism
Curator reviewed
Formula / weight
C5H10O3S · 150.19 g/mol (avg)
Also known as
2-Hydroxy-4-(methylthio) butanoic acid · 2-Hydroxy-4-(methylthio)butanoic acid · alpha-Hydroxy-gamma-(methylmercapto)butyric acid · alpha-Hydroxy-gamma-(methylthio)butyric acid · DL-2-hydroxy-4-(methylthio)-butyric acid

Resolves to

Compound
UNIIZ94465H1Y7CAS583-91-5ChEMBLCHEMBL2104213ChEBI137228
Clinical / RWD
RxNorm1738095
Structure
InChIKeyONFOSYPQQXJWGS-UHFFFAOYSA-NSMILESCSCCC(O)C(O)=O
Targets
P17174GOT1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Desmeninol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In